LEIGH MINCHEW: Open Payments
NPI 1265732994 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 12 payments from 9 companies in 2025. Trend: 2023 $469 · 2024 $1,019 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Incyte Corporation | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $28 |
| PFIZER INC. | 1 | $27 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $16 |
Products named: LYNPARZA, JEMPERLI, MONJUVI, LIBTAYO, Enhertu, TIVDAK, MONOFERRIC, KISQALI.
Industry payments across AL — which companies pay providers there.
